Tregenna Surgical Care Limited 11799153 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 11799153 2023-02-01 2024-01-31 11799153 2024-01-31 11799153 core:RetainedEarningsAccumulatedLosses 2024-01-31 11799153 core:ShareCapital 2024-01-31 11799153 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 11799153 core:FurnitureFittingsToolsEquipment 2024-01-31 11799153 core:MotorVehicles 2024-01-31 11799153 bus:SmallEntities 2023-02-01 2024-01-31 11799153 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 11799153 bus:FullAccounts 2023-02-01 2024-01-31 11799153 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 11799153 bus:RegisteredOffice 2023-02-01 2024-01-31 11799153 bus:Director1 2023-02-01 2024-01-31 11799153 bus:Director2 2023-02-01 2024-01-31 11799153 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 11799153 core:FurnitureFittingsToolsEquipment 2023-02-01 2024-01-31 11799153 core:MotorVehicles 2023-02-01 2024-01-31 11799153 core:PlantMachinery 2023-02-01 2024-01-31 11799153 countries:England 2023-02-01 2024-01-31 11799153 2023-01-31 11799153 core:FurnitureFittingsToolsEquipment 2023-01-31 11799153 core:MotorVehicles 2023-01-31 11799153 2022-02-01 2023-01-31 11799153 2023-01-31 11799153 core:RetainedEarningsAccumulatedLosses 2023-01-31 11799153 core:ShareCapital 2023-01-31 11799153 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 11799153 core:FurnitureFittingsToolsEquipment 2023-01-31 11799153 core:MotorVehicles 2023-01-31 iso4217:GBP xbrli:pure

Registration number: 11799153

Tregenna Surgical Care Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 January 2024

 

Tregenna Surgical Care Limited

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Tregenna Surgical Care Limited

(Registration number: 11799153)
Abridged Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

1,352

13,188

Current assets

 

Debtors

8,388

14,767

Cash at bank and in hand

 

38,879

5,358

 

47,267

20,125

Creditors: Amounts falling due within one year

(7,426)

(3,644)

Net current assets

 

39,841

16,481

Total assets less current liabilities

 

41,193

29,669

Provisions for liabilities

(3,635)

-

Net assets

 

37,558

29,669

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

37,458

29,569

Total equity

 

37,558

29,669

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

Tregenna Surgical Care Limited

(Registration number: 11799153)
Abridged Balance Sheet as at 31 January 2024

Approved and authorised by the Board on 21 October 2024 and signed on its behalf by:
 

Dr S Dixon

Director

Dr P M King

Director

 

Tregenna Surgical Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 21 October 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Tregenna Surgical Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor Vehicles

18% Reducing Balance

Plant and Machinery

20% Reducing Balance

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 4).

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 February 2023

-

26,000

26,000

Additions

1,690

-

1,690

Disposals

-

(26,000)

(26,000)

At 31 January 2024

1,690

-

1,690

Depreciation

At 1 February 2023

-

12,812

12,812

Charge for the year

338

-

338

Eliminated on disposal

-

(12,812)

(12,812)

At 31 January 2024

338

-

338

Carrying amount

At 31 January 2024

1,352

-

1,352

At 31 January 2023

-

13,188

13,188